Effect of temperature on the formation of liquid phase-separating giant unilamellar vesicles (GUV)

BIOTEC, Biophysics Research Group, Technical University Dresden, Tatzberg 47-51, 01307 Dresden, Germany.
Chemistry and Physics of Lipids (Impact Factor: 2.42). 06/2012; 165(6):630-7. DOI: 10.1016/j.chemphyslip.2012.06.006
Source: PubMed


Giant unilamellar vesicles (GUVs) are widely used as model systems to study both, lipid and membrane protein behavior. During their preparation by the commonly applied electroformation method, a number of issues must be considered to avoid the production of artifacts due to a poor lipid hydration and protein degradation. Here we focus on the effect of preparation temperature on GUVs composed of the most commonly used domain-forming mixture dioleoylelphospatidylcholine/shingomyelin/cholesterol (DOPC/SM/chol) (2/2/1). Lower production temperatures are generally preferable when aiming at a functional reconstitution of proteins into the membrane. On the other hand, lower growth temperature is suspected to alter the lipid composition and the yield of phase-separating vesicles. By confocal imaging, we find that vesicles prepared significantly above and below the melting temperature T(m) have the same overall morphology, similar size distributions of vesicles and a similar area coverage by liquid-ordered (L(o)) domains. However, a large population analysis indeed reveals a different overall yield of phase-separating vesicles. Two-focus scanning fluorescence correlation spectroscopy measurements did not show any divergence of lipid analog mobility in (L(o)) and (L(d)) phases in vesicles prepared at different temperatures, indicating that the lowered growth temperature did not influence the lipid organization within the two phases. Moreover, the expected advantages of lower preparation temperature for proteo-GUVs could be exemplified by the reconstitution of voltage dependent anion channel (VDAC) into DOPC/SM/chol GUVs, which aggregates at high, but not at low preparation temperatures.

Download full-text


Available from: Remigiusz Worch, Feb 13, 2014
32 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hybrid polymer–lipid and polymer–cholesterol submicron unilamellar vesicles with a diameter of 200 nm based on poly(dimethylsiloxane)-block-poly(2-methyl-oxazoline) (PDMS-b-PMOXA) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were prepared by using the film-hydration and extrusion method. The vesicles were extensively characterized via dynamic and static light scattering (DLS and SLS), dual-color fluorescence cross-correlation spectroscopy (DC-FCCS), cryogenic transmission electron microscopy (cryo-TEM) and atomic force microscopy imaging and force spectroscopy (AFM). The combination of these techniques provides information about the vesicle size, shape and long-term stability as well as the mechanical properties. DC-FCCS proved the formation of hybrid vesicles containing both components. Cryo-TEM and AFM studies revealed that the presence of cholesterol in vesicle membranes leads to a higher packing density resulting in a reduced membrane thickness and a significantly increased bending stiffness compared to pure polymersomes and polymer–lipid vesicles.
    Soft Matter 06/2013; 9(25):5883-5890. DOI:10.1039/C3SM50733E · 4.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vesosomes - hierarchical assemblies consisting of membrane-bound vesicles of various scales - are potentially powerful models of cellular compartmentalization. Current methods of vesosome fabrication are labor-intensive and offer little control over the size and uniformity of the final product. We developed an automated vesosome formation platform using a microfluidic device and a continuous flow microcentrifuge. In the microfluidic device, water-in-oil droplets containing nanoscale vesicles in the water phase were formed using T-junction geometry; a lipid monolayer is formed at the oil/water interface. These water-in-oil droplets were then transferred to the continuous-flow microcentrifuge immediately. When a water-in-oil droplet passes through a second lipid monolayer formed in the continuous flow microcentrifuge, a bilayer-encapsulated vesosome is created, with all of the contents of the aqueous phase encapsulated within the vesosome. Encapsulation of nanoscale liposomes within the outer vesosome membrane was confirmed by fluorescence microscopy. Laser diffraction analysis showed that the vesosomes we fabricated were uniform (Coefficient of variation of 0.029). The yield of the continuous-flow microcentrifuge is high, with over 60% of impinging water droplets being converted to vesosomes. Our system provides a fully automatable route to generate vesosomes encapsulating arbitrary contents. The method employed in this work is simple and readily applied to a variety of systems, providing a facile platform for fabricating multicomponent carriers and model cells.
    Biotechnology Journal 11/2013; 8(11). DOI:10.1002/biot.201200388 · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We established a method to prepare giant plasma membrane vesicles (GPMVs) by using cysteine mutants of the proapoptotic peptide (PAP) Ac-R7-GG-KLAKLAKKLAKLAK. A cysteine scan revealed that cytotoxicity and GPMV formation were dependent on the cysteine position within the PAP sequence. In comparison to GPMVs prepared by extensive treatment with paraformaldehyde (PFA) and dithiothreitol (DTT), we produced GPMVs from HeLa cells at much lower concentrations of the blebbing agent. We found that only GPMVs derived from cysteine containing PAP showed lipid phase separation. This membrane model was applied to investigate phase partitioning of two relevant membrane proteins: influenza virus hemagglutinin (HA) and tetherin clamping budding HI Virus to infected cells. For tetherin we show for the first time exclusion from cholesterol rich domains in a GPMV model documenting the potential of our approach for membrane partitioning studies. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
    ChemBioChem 04/2015; 16(9). DOI:10.1002/cbic.201500045 · 3.09 Impact Factor